TMC Acquisition LLC dba Tailor Made Compounding recalls Teriparatide 226mcg/ml Injectable, 4 Pre-filled Syringes, 0.25 mL-Syringe, Refrigerate, Tailor Made Compounding
Recalled July 20, 2022 · FDA recall D-1229-2022 · TMC Acquisition LLC
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
12 syringes
Sold at
Nationwide USA and Puerto Rico
Description
Lack of Assurance of Sterility
Product
Teriparatide 226mcg/ml Injectable, 4 Pre-filled Syringes, 0.25 mL-Syringe, Refrigerate, Tailor Made Compounding
Manufacturer(s)
TMC Acquisition LLC dba Tailor Made Compounding
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →